• SENSEX 79,212.53
    -588.90 (--0.74%)
  • BANKNIFTY 54,664.05
    -537.35 (--0.97%)
  • Apollo Hospitals
    6,900.70 5,690.80(%)
  • Waaree Energies
    2,590.20 1,808.65(%)
  • Reliance Industr
    1,288.00 1,115.55(%)
  • SpiceJet
    55.49 79.90(%)
  • Axis Bank
    1,145.75 934.00(%)
  • Dixon Technolog.
    16,092.55 7,772.55(%)
  • Suzlon Energy
    56.78 37.95(%)
  • Vodafone Idea
    7.44 6.60(%)
  • SBI Life Insuran
    1,763.00 1,935.00(%)
  • Tata Motors
    651.45 542.55(%)
  • Bharat Electron
    293.70 221.00(%)
  • Tata Power Co.
    382.00 326.25(%)
  • Reliance Power
    40.91 23.26(%)
  • Eternal Ltd
    226.95 146.85(%)
  • HDFC Bank
    1,891.90 1,430.15(%)
  • Jio Financial
    249.15 198.60(%)
  • Mazagon Dock
    2,585.00 1,046.00(%)
  • Adani Energy Sol
    907.00 588.25(%)
  • Nip. India Nifty
    266.61 242.12(%)
  • Adani Green
    904.00 758.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sequent Scientific Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • MNC Associate
  • BSE Code : 2086.0
  • ISIN : INE807F01027
148.12 -6 (-3.84%)
  • As on 25 Apr 2025 (EOD)

  • Today’s Low

    146.57

  • Today’s High

    155.19

  • Open

    154.90

  • Perv Close

    154.04

  • 52W Low

    92.05

  • 52W High

    240.70

Key Indicators

  • P/E(TTM)

    200.27

  • Mar.Cap (₹Cr.)

    3,707.47

  • Div & Yield %

    0.00

  • Book Value(₹)

    44.30

  • Debt-Equity Ratio

    -3.84

  • AGM Date

    25-Apr-2025

  • EPS

    0.74

  • P/E Ratio

    200.27

Financials Ratios

  • Debt-Equity Ratio

    0.69

  • Mar.Cap (₹Cr.)

    3,707.47

  • RONW (%)

    -3.09

  • ROCE (%)

    0.45

Score Board

  • Equity (₹ in Cr.)

    50.06

  • BV (₹)

    44.30

  • Sales( ₹ in Cr.)

    168.52

  • NP (in Cr.)

    2.31

  • NP Var(%)

    138.0

  • Div%

    0.0

  • CPS (₹)

    0.40

  • EPS (₹)

    0.10

  • Traded Value (₹ in Lakhs)

    3,850.90

  • 52 Week High

    240.70

  • 52 Week Low

    92.05

  • Price BSE

    154.0

  • Price NSE

    154.00

  • Market Capital( in Cr.)

    3,850.90

  • P/C Ratio

    342.60

  • P/E Ratio

    1,668.00

  • Price Vs.BV

    0.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 168.52 222.69 219.63 265.46 227.33 166.26
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 168.52 222.69 219.63 265.46 227.33 166.26
Other Income 45.98 28.24 27.64 19.97 14.56 13.96
Stock Adjustments -5.35 -19.42 19.73 15.56 3.89 2.95
Total Income 209.15 231.51 267.00 300.99 245.78 183.17
EXPENDITURE :            
Raw Materials 102.54 116.50 128.39 124.43 116.93 97.57
Power and Fuel Cost 12.89 13.93 11.96 12.77 12.74 8.52
Employee Cost 30.05 36.66 27.38 22.42 17.10 10.71
Other Manufacturing Expenses 26.21 41.54 52.53 57.73 50.56 39.93
Selling and Administration Expenses 17.86 19.49 19.40 20.27 9.98 8.36
Miscellaneous Expenses 6.54 1.52 0.45 10.68 1.68 1.43
Employee Benefit Expenses 30.05 36.66 27.38 22.42 17.10 10.71
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 196.09 229.63 240.11 248.29 208.98 166.52
Operating Profit 13.06 1.88 26.89 52.70 36.80 16.64
Interest 4.36 2.51 1.61 2.68 5.04 3.22
Gross Profit 8.70 -0.63 25.28 50.02 31.76 13.42
Depreciation 8.94 9.12 9.59 9.13 8.95 7.22
Profit Before Tax -0.24 -9.75 15.69 40.89 22.81 6.20
Current Tax 0.46 -0.57 0.37 6.09 3.18 -0.05
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.32 -3.09 0.52 2.69 -1.71 -1.33
Reported Net Profit 0.62 -6.08 14.80 32.11 21.34 7.59
Extraordinary Items -1.69 0.00 0.00 -0.75 0.00 0.00
Adjusted Net Profit 2.31 -6.08 14.80 32.86 21.34 7.59
Adjustment below Net Profit 2.65 0.09 0.07 43.38 -1.30 0.32
P & L Balance brought forward 38.76 30.56 28.03 -47.47 -62.65 -70.55
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 -14.19 12.34 0.00 4.86 0.00
P & L Balance carried down 42.03 38.76 30.56 28.03 -47.47 -62.65
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 25.00 0.00 10.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.50 0.00 0.20
Earnings Per Share-Unit Curr 0.02 -0.24 0.60 1.29 0.86 0.31
Earnings Per Share(Adj)-Unit Curr 0.02 -0.24 0.60 1.29 0.86 0.31
Book Value 43.59 42.43 41.55 41.45 35.68 37.18
Book Value(Adj)-Unit Curr 43.59 42.43 41.55 41.45 35.68 37.18

Shareholding Pattern

  • Promoter Group

    52.61%

  • Public Share Holding

    47.23%

  • Custodian

    0.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 131,680,103 52.61 131,680,103 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 131,680,103 52.61 131,680,103 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 15,138,675 6.05 15,138,675 54
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 25,590,695 10.22 25,590,695 8
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 6,502,246 2.60 6,502,246 14
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 47,231,616 18.87 47,231,616 76
2] Non Institution
Bodies Corporate 6,671,804 2.67 6,671,804 895
Clearing Members 11,998 0.00 11,998 9
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,163,027 1.26 3,163,027 2,736
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,465,103 0.98 2,465,103 2,151
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,627,619 2.65 6,627,619 29
Individuals holding nominal share capital up to Rs. 1 lakh 52,010,885 20.78 51,973,380 152,251
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 4,690 0.00 4,690 2
Others 22,900 0.01 22,900 1
Sub Total 70,978,026 28.36 70,940,521 158,074
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 412,250 0.16 412,250 1
Total Shares held by Custodians and against which Depository Receipts have been issued 412,250 0.16 412,250 1
Grand Total ( A + B + C ) 250,301,995 100.00 250,264,490 158,152

Company Background

Sequent Scientific LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Sequent Scientific Ltd
  • BSE Code : 2086.0
  • ISIN : INE807F01027

  • Incorporation Year

    1985

  • Registered Office

    301 Dosti Pinnacle 3rd Floor
    Plot E7 Road No 22 Wagle Indl, Thane,
    Maharashtra-400604

  • Telephone

    91-022-41114777

  • FAX

    91-022-41114754

  • Chairman

    Kamal K Sharma

  • Managing Director

    Sharat Narasapur

  • Company Secretary

    PHILLIP TROTT

  • Auditor

    SRBC & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Adroit Corp. Services Pvt Ltd
    19/20 Jaferbhoy Ind,
    1st Floor Makwana Rd,Marol Naka
    Mumbai - Mumbai - 400 059

Sequent Scientific Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sequent Scien. 148.20 214.50 168.52 242.95 0.52
Abbott India 29,747.90 6,097.18 5,848.91 47.37 44.71
Astrazeneca Phar 8,728.45 1,330.33 1,295.53 225.02 33.26
P & G Health Ltd 5,074.25 1,166.89 1,151.26 35.60 39.76
Glaxosmi. Pharma 2,804.05 3,530.73 3,407.25 55.76 44.44
Cipla 1,525.50 17,645.00 16,574.34 26.15 20.10
Amrutanjan Healt 656.65 437.58 421.23 38.49 20.84
Guj. Themis Bio. 283.70 174.19 169.82 58.74 44.82
Fermenta Biotec. 278.75 315.24 307.09 26.42 4.10
Bliss GVS Pharma 122.05 638.96 605.46 27.93 11.19
Ambalal Sarabhai 37.95 11.70 3.81 16.22 1.92